MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
North America
United States of America
Government: U.S. States & Territories
Government: States (U.S.)
Colorado
Industry: Colorado
ArcherDX
Attachments
Home | ArcherDX
Parents
2020: ArcherDX, Geneoscopy, Phagenesis win FDA breakthrough device designations
FDA _ Breakthrough Devices Program
Finance & Acquisitions: Invitae
Industry: Colorado
Children
2020: ArcherDX drops IPO plans in favor of a $1.4B takeover by Invitae
2020: Genetic Testing Behemoth Invitae Rockets 45% On $1.4 Billion Acquisition _ ArcherDX
After inking a deal with Illumina ArcherDX detailed plans to seek approval for the product.
ArcherDX is working on a test designed to enable timely therapeutic interventions for people with cancer.
Boulder, Colorado
Dubbed Personalized Cancer Monitoring, the company describes its technology as a way to “enable local labs to assess therapy success and identify disease recurrence much earlier than current standard of care such as imaging or antigen test modalities
Making successful treatment more likely.